Evidence map›Paper›PMID 32370028›Full record

ArticleJournal of clinical medicine2020

Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors.

Masaya Iwamuro, Koji Miyahara, Chihiro Sakaguchi, Ryuta Takenaka, Sayo Kobayashi, Hirokazu Mouri, Shigetomi Tanaka, Tatsuya Toyokawa, Shouichi Tanaka, Mamoru Nishimura and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Masaya IwamuroDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.ORCID 0000-0002-1757-5754
Koji MiyaharaDepartment of Internal Medicine, Hiroshima City Hospital, Hiroshima 730-8518, Japan.
Chihiro SakaguchiDepartment of Endoscopy, National Hospital Organization Shikoku Cancer Center, Matsuyama 791-0280, Japan.
Ryuta TakenakaDepartment of Internal Medicine, Tsuyama Chuo Hospital, Tsuyama 708-0841, Japan.
Sayo KobayashiDepartment of Internal Medicine, Fukuyama City Hospital, Fukuyama 721-8511, Japan.
Hirokazu MouriDepartment of Gastroenterology and Hepatology, Kurashiki Central Hospital, Okayama 710-8602, Japan.
Shigetomi TanakaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu 760-8557, Japan.
Tatsuya ToyokawaDepartment of Gastroenterology, Fukuyama Medical Center, Fukuyama 720-8520, Japan.ORCID 0000-0002-8658-5892
Shouichi TanakaDepartment of Gastroenterology, Iwakuni Clinical Center, Iwakuni, Yamaguchi 740-8510, Japan.
Mamoru NishimuraDepartment of Internal Medicine, Okayama City Hospital, Okayama 700-0962, Japan.
Kenji YamauchiDepartment of Gastroenterology, Mitoyo General Hospital, Kan-onji 769-1695, Japan.ORCID 0000-0002-1621-6477
Takehiro TanakaDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Hiroyuki OkadaDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Okayama University · JPIwakuni Medical Center · JPFukuyama City Hospital · JPFukuyama University · JPHiroshima Prefectural Hospital · JPKurashiki Central Hospital · JPMito Saiseikai General Hospital · JPOkayama Prefecture · JPShikoku Cancer Center · JPTsuyama Chuo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There have been no comparative studies investigating the results of 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) in patients with gastric mesenchymal tumors, including leiomyomas, leiomyosarcomas, schwannomas, and gastrointestinal stromal tumors (GISTs). We retrospectively reviewed the data of 142 patients with pathologically diagnosed gastric mesenchymal tumors treated at 11 institutions. We analyzed the correlation between the maximum standardized uptake value (SUVmax) evaluated using fluorodeoxyglucose-positron emission tomography (FDG-PET) and the tumor size. The correlation between the SUVmax and mitotic index was also investigated in GISTs. The SUVmax (mean ± standard deviation) was 0.5 ± 0.6 in very low-risk GISTs (

Indexed as

18F-fluorodeoxyglucose-positron emission tomographygastric neoplasmsgastrointestinal stromal tumormesenchymal tumorschwannoma

Identifiers

PMID32370028
PMCPMC7290475
OpenAlexW3022685469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.